HLB Life Science Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 1,303.02 million compared to KRW 619.96 million a year ago. Net loss was KRW 5,983.4 million compared to KRW 54,277.44 million a year ago.

Basic loss per share from continuing operations was KRW 58 compared to KRW 565 a year ago. Basic loss per share was KRW 58 compared to KRW 565 a year ago.